April 14, 2021
Business News

ERS Genomics Expands Team With Appointment of Jon Kratochvil as VP Business Development

DUBLIN–()–ERS Genomics Limited (“ERS”), which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, today announced the appointment of Jon Kratochvil as Vice-President for Business Development & Licensing for North America.

With over 30 years of experience, Jon becomes a core member of ERS’ global team. Jon joins ERS from MilliporeSigma where he was Director of Business Development and Licensing, with responsibility for all global development opportunities for the company’s gene editing and novel modalities technologies. In his role as Business Development Director for Washington University Jon was pivotal in generating over $70…

Click here to view the original article.

Related Posts

You might also like ...

AlixPartners Disruption Index Reveals That Business Leaders Don’t Consider COVID-19 to Be the Most Disruptive Force Impacting Their Organization
Germany’s Supreme Court Rules in Solvay’s Favor on Patent Case With Neo
AON Splash Image
OSI Systems Receives $16 Million Contract for Security Inspection Systems